Grant recipients
In accordance with the grant from the Novo Nordisk Foundation, the Danish Diabetes Academy is allocating co-financed PhD scholarships of each 550.000 DKK, Post Doc fellowships of each 600.000 DKK per year, and a number of Visiting Scientist grants.
The list below features the Danish Diabetes Academy funded PhD and Post Doc fellows, who have received a grant in 2015-2016 and a complete list of Visiting Scientist 2013-2016. Additionally, recipients of exchange travel grants 2016 are featured.
The overall aim of this PhD project is to explore the influence of the oral microbiota on cardio metabolic traits in 702 well phenotyped individuals at different risk of type 2 diabetes mellitus from the ADDITION-Pro cohort. In a closer look, we have four different goals for this project:
For the past decades the prognosis for children with acute lymphoblastic leukaemia (ALL) has improved significantly with more than 85% being cured. This in part reflects intensive chemotherapy (amongst others, asparaginase) combined with high doses of steroids. However, the burden of therapy has increased proportionally.
A mechanistic understanding of organ regeneration is fundamental for developing tissue replacement therapies with which to treat injury or disease. With the overarching goal of understanding the regenerative capacity and cellular plasticity of the developing pancreas, I aim to explore the extent of tissue recovery, revealing the origin of the regenerating pancreatic cells and analyzing the signaling pathways involved in this process.
Insulin resistance is a central feature of T2DM and is the primary target for therapy. Nevertheless, the pathological consequences of T2DM predominantly relate to cerebro- and cardiovascular disease (CVD), representing the leading cause of morbidity and mortality in T2DM. Up to 60% of all deaths in T2DM are directly related to CVD, whilst patients with T2DM develop microvascular complications (e.g. retinopathy, nephropathy and neuropathy).
Around 3-10% of patients clinically diagnosed with type 2 diabetes (T2D) have circulating autoantibodies as seen in type 1 diabetes (T1D). This diabetic subtype is termed latent autoimmune diabetes in adults (LADA), and it is the second most common type of diabetes only exceeded in numbers by T2D. Despite the prevalence, LADA is far less studied than its more renowned counterparts T1D and T2D.
The number of people suffering from obesity and obesity-related disorders such as Type 2 Diabetes (T2DM) is increasing worldwide. To break this escalation new therapeutic options are needed. Brown adipose tissue (BAT), also known as brown fat, possesses the ability to “burn” calories by uncoupling the oxidative phosphorylation pathway in the mitochondria.
Fully automated control of blood glucose (BG) level by means of a portable artificial pancreas (AP) will substantially increase the quality of life for type 1 diabetes patients, by reducing the burden of meticulous considerations about manual adjustment of insulin dosage and timing.